Literature DB >> 3995514

Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.

D E Brenner, N B Rosenshein, M Dillon, H W Jones, A Forastiere, S Tipping, L S Burnett, F A Greco, P H Wiernik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3995514

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  An evaluation of combination 5-fluorouracil and spirogermanium in the treatment of advanced colorectal carcinoma.

Authors:  M L McMaster; F A Greco; D H Johnson; J D Hainsworth
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 2.  Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide.

Authors:  A G Schauss
Journal:  Biol Trace Elem Res       Date:  1991-06       Impact factor: 3.738

Review 3.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.